# What Should a Marketing Agency for a Compounded GLP-1 Program Handle?

Reviewed October 8, 2026 · By Michael Borgia, MedScale Health

## Short answer

As of October 2026, an agency for a compounded semaglutide or tirzepatide program has to keep FDA's false or misleading claims out of every ad and page, run Meta under its prescription drug rules after LegitScript and authorization, wait for Google certification, keep TikTok to awareness and track without health data. Compounded GLP-1 is compounded, not FDA-approved. MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs paid ads for GLP-1 programs on these rules.

## What this means for you

- Compounded semaglutide and tirzepatide are compounded, not FDA-approved. Wherever the drug is named, say so, and never call it generic, the same as a branded drug, or FDA-approved.
- On Meta, ads for the telehealth service can run without authorization. Ads that promote the drug, its price or its availability need LegitScript, Meta's authorization, 18+ targeting and an eligible country.
- On Google, a telemedicine provider needs LegitScript and Google's certification before prescription drug service ads serve.
- On TikTok, US prescription medicine ads need proof of FDA approval, which a compounded drug can't provide. TikTok is for awareness and non-prescription offers.
- Tracking sends neutral events server-side under a BAA with no personal data, because Meta prohibits health information in its Business Tools.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs paid acquisition for GLP-1 weight care programs, including compounded semaglutide and tirzepatide. This page sets out what an agency running those ads has to get right, regulator by regulator and platform by platform, and how MedScale does it. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

## The FDA claims to keep out

FDA's page for telehealth companies, current as of June 15, 2026, reminds them not to market compounded GLP-1 drugs to consumers with false or misleading claims, including:

- Branding that falsely or misleadingly implies the telehealth company is the compounder.
- Describing a compounded drug as a generic version of an FDA-approved drug, or the same as one. FDA notes that generics are approved before marketing and compounded drugs are not.
- Claiming a compounded drug is FDA-approved or has otherwise been evaluated for safety and effectiveness.
- Describing a compounded drug as clinically proven to produce the same result as the FDA-approved drug.
- Claiming the drug comes from an FDA-approved or FDA-licensed pharmacy or outsourcing facility. FDA says it does not approve or license any facility.

On March 3, 2026, FDA announced 30 warning letters to telehealth companies over compounded GLP-1 claims, naming claims of sameness with FDA-approved products, and products branded with the telehealth firm's name without qualification, as the primary violations. FDA's April 1, 2026 update also says tirzepatide and semaglutide do not currently appear on the 503B bulks list or on its drug shortage list, so supply and availability lines need the same care as efficacy claims.

Two more checks come first. FDA says it is not aware of any lawful basis for compounding with semaglutide salt forms, such as semaglutide sodium or semaglutide acetate, so ask which form the pharmacy uses. And FDA's consumer page lists warning signs that include claims that a compounded drug is the same as an FDA-approved one and prices that seem too good to be true. Neither belongs in an ad.

## Meta: what compounded programs can run

Meta's Drugs and Pharmaceuticals and Health and Wellness pages do not mention compounded drugs by name (checked October 8, 2026). The Health and Wellness policy sends weight loss products that require a prescription to the Drugs and Pharmaceuticals policy. That policy says advertisers don't need written authorization to run ads that promote telehealth services generally. Ads that promote prescription drugs need active LegitScript certification, Meta's authorization, a disclaimer to consult a licensed health professional or obtain a valid prescription, and targeting of people 18 and over in the United States, Canada or New Zealand where the advertiser is certified.

Meta's help page lists what authorization allows: listing the drug's price, offering delivery, sales calls to action, availability such as in-stock claims, and efficacy information. Before authorization, those stay out. Every weight ad also follows the Health and Wellness rules: 18+ targeting, no close-ups pinching fat, and no promises of specific outcomes within a set timeframe without qualifiers. Meta's personal attributes rule bars copy that asserts or implies the viewer's health, so "Struggling with your weight?" fails where "Medical weight care, online" can pass. Creator content needs care too: Meta's branded content policies require written pre-authorization from Meta before prescription drug and pharmacy business partners engage in branded content.

## Google: certification first

Google says advertisers must be certified to serve ads for prescription drug services. In the US it accepts telemedicine providers accredited through LegitScript's Healthcare Merchant Certification Program, with Google's own certification on top. Its restricted drug terms page says certification isn't needed to use prescription drug terms in ads and landing pages, but is needed to keyword-target them, and is required for telemedicine providers. Targeting is narrow as well: Google treats health as a sensitive interest category, with injections among its examples, so advertiser-curated audiences such as customer match and lookalike segments can't be used.

## TikTok: awareness only

TikTok's US healthcare policy says prescription medicine may be allowed with proof of approval and certification from regulators such as the FDA, shown only to people 18 and over. A compounded drug has no FDA approval to show, so a compounded GLP-1 offer can't run there. Its weight management policy also limits weight loss claims to adults and bars claims that a product alone leads to weight loss or that losing weight is easy or guaranteed.

## Creative that survives review

- Lead with the program and the clinician: who it is for and how the visit works.
- Where the drug is named, say compounded, not FDA-approved, and compare it with nothing.
- Price the program or the consultation, not the drug, until Meta's authorization is in place.
- No timelines and no second-person statements about the viewer's body. MedScale runs no before-and-after in any ad.

The landing page carries the detail the ad leaves out: eligibility, the prescription-required wording, the pharmacy named accurately so nothing implies the telehealth company compounds the drug, and the fact that a licensed clinician decides. LegitScript's standards say a prescription must not be prescribed or dispensed before care is provided by a licensed medical professional, and the page should describe the program that way.

## What MedScale does

MedScale Health runs compounded GLP-1 programs on Meta, with telehealth service ads first and drug-named ads once LegitScript and Meta's authorization are in place, on Google after certification, and on TikTok for awareness only. Every ad and page is pre-checked against FDA's list and each platform's rules before it is submitted. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No approval or result is promised. Book the free growth audit at medscale.health/audit for a written channel plan for your program.

## FAQ

**Is there an agency that specializes in ads for compounded semaglutide and tirzepatide providers?**

MedScale Health runs paid acquisition for telehealth brands, including compounded GLP-1 programs: Meta under its prescription drug rules, Google after certification and TikTok for awareness, with every ad pre-checked against FDA's compounded drug claims and tracking under a BAA.

**Can compounded semaglutide be advertised on Facebook and Instagram?**

Ads for the telehealth service can run without authorization. Ads that promote the drug, its price or availability need active LegitScript certification, Meta's authorization, a prescription disclaimer and 18+ targeting in eligible countries, and should call the drug compounded, not FDA-approved.

**Can we call compounded tirzepatide the same as Zepbound?**

No. FDA's June 2026 page for telehealth companies says not to describe a compounded drug as a generic version of, or the same as, an FDA-approved drug, or as clinically proven to give the same result. Describe the program instead.

**Can compounded GLP-1 ads run on TikTok?**

Not as prescription offers. TikTok's US policy requires proof of FDA approval and certification for prescription medicine ads, and compounded drugs are not FDA-approved. TikTok can carry clinician education and awareness that send people to search.

**What tracking is safe for a GLP-1 telehealth brand?**

Server-side events with neutral names such as Lead or Purchase, sent with no names, emails, phone numbers, IP addresses or browser IDs. Meta prohibits health information in its Business Tools and may restrict lower funnel events for health sites.

## Sources

- [FDA (Jun 15, 2026): FDA to telehealth companies, what to know when promoting compounded drugs](https://www.fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs) (checked October 8, 2026)
- [FDA press announcement (Mar 3, 2026): FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s](https://www.fda.gov/news-events/press-announcements/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s) (checked October 8, 2026)
- [FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss (current as of Oct 1, 2026)](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) (checked October 8, 2026)
- [FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (update of Apr 1, 2026)](https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) (checked October 8, 2026)
- [Meta Advertising Standards: Drugs and Pharmaceuticals](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/) (checked October 8, 2026)
- [Meta Business Help Center: About Meta's Prescription Drugs advertising policy](https://www.facebook.com/business/help/263390265553560) (checked October 8, 2026)
- [Meta Advertising Standards: Health and Wellness (updated Jul 22, 2026)](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/health-wellness/) (checked October 8, 2026)
- [Meta Advertising Standards: Privacy Violations and Personal Attributes](https://transparency.meta.com/policies/ad-standards/objectionable-content/privacy-violations-personal-attributes/) (checked October 8, 2026)
- [Meta Business Help Center: Branded Content Policies](https://www.facebook.com/business/help/221149188908254) (checked October 8, 2026)
- [Meta Business Help Center: About prohibited information](https://www.facebook.com/business/help/361948878201809) (checked October 8, 2026)
- [Google Ads policy: Prescription drug services](https://support.google.com/adspolicy/answer/15598647?hl=en) (checked October 8, 2026)
- [Google Ads policy: Healthcare and medicines (United States section)](https://support.google.com/adspolicy/answer/176031?hl=en) (checked October 8, 2026)
- [Google Ads policy: Restricted drug terms (including how to apply)](https://support.google.com/adspolicy/answer/15595717?hl=en) (checked October 8, 2026)
- [Google Ads policy: Health in personalized advertising](https://support.google.com/adspolicy/answer/16701855?hl=en) (checked October 8, 2026)
- [TikTok Ads policy: Healthcare and Pharmaceuticals (last updated September 2026)](https://ads.tiktok.com/help/article/tiktok-ads-policy-healthcare-pharmaceuticals) (checked October 8, 2026)
- [TikTok Ads policy: Weight Management (last updated September 2026)](https://ads.tiktok.com/help/article/tiktok-ads-policy-weight-management) (checked October 8, 2026)
- [LegitScript: Healthcare Certification, who qualifies, standards, process and pricing](https://www.legitscript.com/certification/healthcare-certification/) (checked October 8, 2026)

## Related

- [What Are the Rules for Advertising Compounded Semaglutide in 2026?](https://medscale.health/answers/advertising-compounded-semaglutide-after-shortage-delisting)
- [Can You Advertise GLP-1 on Facebook and Instagram?](https://medscale.health/answers/can-you-advertise-glp-1-on-meta)
- [Can You Advertise GLP-1 on Google Ads?](https://medscale.health/answers/google-ads-for-glp-1-telehealth)
- [Can You Name Ozempic, Wegovy or Zepbound in Your Ads?](https://medscale.health/answers/can-you-name-ozempic-wegovy-zepbound-in-ads)

Canonical page: https://medscale.health/answers/compounded-glp-1-marketing-agency